EU PHARMA PATENT SETTLEMENT LEVELS STILL HEALTHY SAYS COMMISSION
January 1st, 2016
The European Commission has noted that while the number of patent settlements in the European Union (EU) pharmaceutical sector declined in 2014, it is still optimistic that such deals will be used to avoid legal action in future. It says in a report that there were 76 patent settlements concluded between originator and generic companies in the EU pharmaceutical sector in 2014. This is far below the 183 in 2012 and 146 in 2013, but is still much higher than the annual average of 24 during between 2000 and 2008.
This indicated that the Commission’s monitoring ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.